Belite Bio, Inc
Belite Bio, Inc（BLTE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
blte · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$217
Consensus
$208
+49.2% upside
Low
$191
Median: $215 · Last Close: $139.46
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$208.00
49.2% upside
High Target
$217
55.6%
Low Target
$191
37.0%
Current Price
$139.46
as of today
Based on analyst price targets, the BLTE stock price prediction for the next 12 months ranges from $191 to $217. The consensus BLTE price forecast of $208.00 implies 49.2% upside from the current price of $139.46.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $136.58 | ↓ 2.06% |
1-day model range: $135.84–$137.31. Peak: $137.31 (-2.06%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $251 | +80.0% |
| 2028 | $372 | +166.4% |
| 2029 | $479 | +243.1% |
| 2030 | $561 | +302.4% |
| 2031 | — | +344.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BLTE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-03 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-03-03 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-01-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-02 | Mizuho | Upgrade ↑ | Neutral→Outperform |
| 2025-12-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Belite Bio, Inc (BLTE) stock. Of the recent 44 rating actions, 1 were upgrades and 0 were downgrades. 6 analysts currently cover BLTE.
分析师推荐趋势
BLTE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$23M
↓ 95.8% YoY
Revenue Next Year
$243M
↑ 979.2% YoY
EPS This Year
$-3.19
EPS Next Year
$0.84
↓ 126.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast BLTE EPS of $-3.19 for the current fiscal year, based on estimates from 6 analysts. The BLTE revenue forecast is $23M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BLTE 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BLTE 的共识目标价为 $208.00（+49.2% 上行空间），分析师共识为 Buy。
BLTE 的短期预测（明日）为 $136.58（-2.06%）。 BLTE 对 2027 年的股价预测均值为 $251。 BLTE 对 2030 年的预测区间为 $528–$594。
Belite Bio, Inc 在 NASDAQ 上市，代码 BLTE。BLTE 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
BLTE 预测 · 8 个问题根据 6 位华尔街分析师，BLTE 的 12 个月平均目标价为 $208.00，最高 $217.00、最低 $191.00。若有图表，中位目标价可在上方查看。相对当前价 $139.46，隐含约 +49.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.